Botulinum neurotoxins: mechanism of action and therapeutic applications

Smith, 1988 Hatheway, 1995, Botulism: the present status of the disease, Curr. Top. Microbiol. Immunol., 195, 55, 10.1007/978-3-642-85173-5_3 Arnon, 1992, Infant Botulism, 1095 Sakaguchi, 1983, Clostridium botulinum toxins, Pharmac. Ther., 19, 165, 10.1016/0163-7258(82)90061-4 Tacket, 1989, Botulism, 351 Hatheway, 1994, Immunogenicity of the neurotoxins of Clostridium botulinum, 93 Shone, 1995, Growth of Clostridia and preparation of their neurotoxins, Curr. Top. Microbiol. Immunol., 195, 143, 10.1007/978-3-642-85173-5_7 Minton, 1995, Molecular genetics of clostridial neurotoxins, Curr. Top. Microbiol. Immunol., 195, 161, 10.1007/978-3-642-85173-5_8 Montecucco, 1993, Tetanus and botulinum neurotoxins: a new family of metalloproteases, Trends Biochem. Sci., 18, 324, 10.1016/0968-0004(93)90065-U Montecucco, 1995, The structure and function of tetanus and botulinum neurotoxins, Quart. Rev. Biophys., 28, 423, 10.1017/S0033583500003292 Nishiki, 1996, The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a, FEBS Lett., 378, 253, 10.1016/0014-5793(95)01471-3 Black, 1986, Interaction of 125I-labeled neurotoxins with nerve terminals. I. Ultrastructure, autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves, J. Cell Biol., 103, 521, 10.1083/jcb.103.2.521 Dolly, 1984, Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization, Nature, 307, 457, 10.1038/307457a0 Simpson, 1994, Inhibition of vacuolar adenosine triphosphate antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins, J. Pharmacol. Exp. Ther., 269, 256 1995, Vol. 248 Rothman, 1994, Mechanisms of intracellular protein transport, Nature, 372, 55, 10.1038/372055a0 Sudhof, 1995, The synaptic vesicle cycle: a cascade of protein-protein interactions, Nature, 375, 645, 10.1038/375645a0 Hayashi, 1994, Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly, EMBO J., 13, 5051, 10.1002/j.1460-2075.1994.tb06834.x Pellegrini, 1995, Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion, EMBO J., 14, 4705, 10.1002/j.1460-2075.1995.tb00152.x Foran, 1996, Botulinum neurotoxin C1 cleaves both syntaxin and SNAP25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release, Biochemistry, 35, 2630, 10.1021/bi9519009 Osen-Sand, 1996, Common and distinct fusion-proteins in axonal growth and transmitter release, J. Comp. Neurol., 367, 222, 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7 Williamson, 1996, Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on SNAP-25, J. Biol. Chem., 271, 7694, 10.1074/jbc.271.13.7694 Patamello, 1993, Neurotransmission and secretion, Nature, 364, 581, 10.1038/364581b0 Oyler, 1989, The identification of a novel synaptosomal-associated protein, SNAP-25, differently expressed by neuronal subpopulations, J. Cell Biol., 109, 3039, 10.1083/jcb.109.6.3039 Osen-Sand, 1993, Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo, Nature, 364, 445, 10.1038/364445a0 Blasi, 1993, Botulinum neurotoxin C blocks neurotransmitter release by means of cleaving syntaxin, EMBO J., 12, 4821, 10.1002/j.1460-2075.1993.tb06171.x Schiavo, 1995, Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins, J. Biol. Chem., 270, 10566, 10.1074/jbc.270.18.10566 Rossetto, 1994, SNARE motif and neurotoxin recognition, Nature, 372, 415, 10.1038/372415a0 Burgen, 1949, The action of botulinum toxin on the neuro-muscular junction, J. Physiol., 109, 10, 10.1113/jphysiol.1949.sp004364 Borodic, 1994, Pharmacology and histology of the therapeutic application of botulinum toxin, 119 1994 Scott, 1994, Introduction, vii Scott, 1980, Botulinum injection into extraocular muscles as an alternative to strabismus surgery, Ophthalmology, 87, 1044, 10.1016/S0161-6420(80)35127-0 Eleopra, R. et al. The variability in the clinical effect induced by botulinum neurotoxin type A: the role of muscular activity in humans, Mov. Disord. (in press) Ludlow, 1992, Therapeutic use of type F botulinum toxin, New Engl. J. Med., 326, 349, 10.1056/NEJM199201303260516 Carruthers, 1994, Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles, 577 Gui, 1994, Botulinum toxin for chronic and fissure, Lancet, 344, 1127, 10.1016/S0140-6736(94)90633-5 Oguma, K. et al. Structure and function of progenitor toxins produced by Clostridium botulinum types A, C, D and E, in Biomedical Aspects of Clostridial Neurotoxins (Foster, K.A., Shone, C.C. and Hambleton, P., eds), Oxford University Press (in press)